119 related articles for article (PubMed ID: 11168950)
1. Idiopathic IgA nephropathy with segmental necrotizing lesions of the capillary wall.
D'Amico G; Napodano P; Ferrario F; Rastaldi MP; Arrigo G
Kidney Int; 2001 Feb; 59(2):682-92. PubMed ID: 11168950
[TBL] [Abstract][Full Text] [Related]
2. Morphological features in IgA nephropathy.
Ferrario F; Rastaldi MP; Napodano P
Ann Med Interne (Paris); 1999 Feb; 150(2):108-16. PubMed ID: 10392259
[TBL] [Abstract][Full Text] [Related]
3. [Immunosuppressive therapy in IgA glomerulonephritis with chronic renal failure: case study presentation and literature review].
Pozzi C; Del Vecchio L; Locatelli F
G Ital Nefrol; 2002; 19(5):523-8. PubMed ID: 12439840
[TBL] [Abstract][Full Text] [Related]
4. Steroid and cyclophosphamide in IgA nephropathy.
Roccatello D; Ferro M; Cesano G; Rossi D; Berutti S; Salomone M; Piccoli G; Sena LM
Nephrol Dial Transplant; 2000 Jun; 15(6):833-5. PubMed ID: 10831636
[TBL] [Abstract][Full Text] [Related]
5. ANCA-associated crescentic glomerulonephritis with mesangial IgA deposits.
Haas M; Jafri J; Bartosh SM; Karp SL; Adler SG; Meehan SM
Am J Kidney Dis; 2000 Oct; 36(4):709-18. PubMed ID: 11007672
[TBL] [Abstract][Full Text] [Related]
6. IgA nephropathy with severe chronic renal failure: a randomized controlled trial of corticosteroids and azathioprine.
Pozzi C; Andrulli S; Pani A; Scaini P; Roccatello D; Fogazzi G; Pecchini P; Rustichelli R; Finocchiaro P; Del Vecchio L; Locatelli F
J Nephrol; 2013; 26(1):86-93. PubMed ID: 22460183
[TBL] [Abstract][Full Text] [Related]
7. Endothelial cell injury in acute and chronic glomerular lesions in patients with IgA nephropathy.
Kusano T; Takano H; Kang D; Nagahama K; Aoki M; Morita M; Kaneko T; Tsuruoka S; Shimizu A
Hum Pathol; 2016 Mar; 49():135-44. PubMed ID: 26826420
[TBL] [Abstract][Full Text] [Related]
8. Clinical presentation, natural history, and treatment of crescentic proliferative IgA nephropathy.
Tumlin JA; Hennigar RA
Semin Nephrol; 2004 May; 24(3):256-68. PubMed ID: 15156530
[TBL] [Abstract][Full Text] [Related]
9. Treatment of severe Henoch-Schönlein and immunoglobulin A nephritis. A single center experience.
Edström Halling S; Söderberg MP; Berg UB
Pediatr Nephrol; 2009 Jan; 24(1):91-7. PubMed ID: 18931859
[TBL] [Abstract][Full Text] [Related]
10. Randomized controlled clinical trial of corticosteroids plus ACE-inhibitors with long-term follow-up in proteinuric IgA nephropathy.
Manno C; Torres DD; Rossini M; Pesce F; Schena FP
Nephrol Dial Transplant; 2009 Dec; 24(12):3694-701. PubMed ID: 19628647
[TBL] [Abstract][Full Text] [Related]
11. Report on intensive treatment of extracapillary glomerulonephritis with focus on crescentic IgA nephropathy.
Roccatello D; Ferro M; Coppo R; Giraudo G; Quattrocchio G; Piccoli G
Nephrol Dial Transplant; 1995 Nov; 10(11):2054-9. PubMed ID: 8643167
[TBL] [Abstract][Full Text] [Related]
12. Vasculitic IgA nephropathy: prognosis and outcome.
Pankhurst T; Lepenies J; Nightingale P; Howie AJ; Adu D; Harper L
Nephron Clin Pract; 2009; 112(1):c16-24. PubMed ID: 19342865
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of IgA nephropathy with chronic renal failure].
Pozzi C
G Ital Nefrol; 2008; 25 Suppl 44():83-7. PubMed ID: 19048591
[TBL] [Abstract][Full Text] [Related]
14. Cyclophosphamide pulse therapy in advanced progressive IgA nephropathy.
Rasche FM; Klotz CH; Czock D; Karges W; Muche R; Jehle PM; Mertz A; Keller F
Nephron Clin Pract; 2003; 93(4):c131-6. PubMed ID: 12759581
[TBL] [Abstract][Full Text] [Related]
15. Behcet's disease and IgA nephropathy: report of this association in a patient from Brazil and literature review.
Fernandes PF; Júnior GB; Barros FA; Sousa DC; Franco LM; Patrocínio RM
Invest Clin; 2006 Dec; 47(4):405-11. PubMed ID: 17176908
[TBL] [Abstract][Full Text] [Related]
16. Factors predicting progression of IgA nephropathies.
Coppo R; D'Amico G
J Nephrol; 2005; 18(5):503-12. PubMed ID: 16299675
[TBL] [Abstract][Full Text] [Related]
17. Supportive Versus Immunosuppressive Therapy of Progressive IgA nephropathy (STOP) IgAN trial: rationale and study protocol.
Eitner F; Ackermann D; Hilgers RD; Floege J
J Nephrol; 2008; 21(3):284-9. PubMed ID: 18587715
[TBL] [Abstract][Full Text] [Related]
18. The effects of cytotoxic therapy in progressive IgA nephropathy.
Shin JH; Lee JE; Park JH; Lim S; Jang HR; Kwon GY; Huh W; Jung SH; Kim YG; Oh HY; Kim DJ
Ann Med; 2016; 48(3):171-81. PubMed ID: 27031662
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors and therapy assessment of IgA nephropathy: report from a single unit in iran.
Soleymanian T; Najafi I; Salimi BH; Broomand B
Ren Fail; 2011; 33(6):572-7. PubMed ID: 21663387
[TBL] [Abstract][Full Text] [Related]
20. Treatment of progressive IgA nephropathy: an update.
Wang W; Chen N
Contrib Nephrol; 2013; 181():75-83. PubMed ID: 23689569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]